ESC Premium Access

Poster Session 2 - Transcatheter aortic interventions

Event: ESC CONGRESS 2019
Topic: European Society of Cardiology
Session type: Poster Session
Date: 1 September 2019

Congress Session

10 presentations in this session

Impact of surgery for mitral regurgitation at the time of aortic valve replacement

Speaker: Doctor N. Kato (Rochester, US)
Thumbnail

Peripheral vascular access for transcatheter aortic valve implantation: transcarotid versus femoral access

Speaker: Professor T. Folliguet (Creteil, FR)
Thumbnail

The outcome of TAVI in patients with small annulus and the comparison between intra-annular and supra-annular devices in small anulus: From the analysis of the Japanese nationwide registry

Speaker: Doctor K. Meguro (Kanagawa, JP)
Thumbnail

Outcomes of different approaches for severe aortic stenosis: "The Deferred-TAVI", a multicentre study investigating medical and percutaneous therapy in the era of TAVI

Speaker: Doctor F. Bruno (Turin, IT)
Thumbnail

TAVI is associated with less patient-prosthesis-mismatch than surgical aortic valve repair of severe aortic stenosis: A systematic review and meta-analysis

Speaker: Associate Professor C. Abi Khalil (Doha, QA)
Thumbnail

Conduction abnormalities following aortic valve intervention in patients with transthyretin cardiac amyloidosis

Speaker: Doctor D. Haberman (Rehovot, IL)
Thumbnail

Delirium after transcatheter aortic valve implantation (TAVI) under general anaesthesia: incidence, predictors and relation to long-term survival

Speaker: Mr K. Van Der Wulp (Nijmegen, NL)
Thumbnail

Eight-year clinical outcome and valve durability after transcatheter aortic valve implantation

Speaker: Doctor B. Lattuca (Nimes, FR)
Thumbnail

Futility risk model development and validation among patients with aortic stenosis treated with transcatheter aortic valve replacement

Speaker: Doctor A. Bisson (Tours, FR)
Thumbnail

Impact of severe aortic stenosis treatment strategy in low-risk patients: a propensity matched analysis of surgical aortic valve replacement versus transcatheter aortic valve implantation

Speaker: Doctor C. Brizido (Carnaxide, PT)
Thumbnail

10 speakers from this session

Doctor Nahoko Kato

Mayo Clinic, Rochester (United States of America)
0 follower

Professor Thierry Folliguet

University Hospital Henri Mondor, Creteil (France)
6 presentations
0 follower

Doctor Kentaro Meguro

Kitasato University, Kanagawa (Japan)
0 follower

Doctor Francesco Bruno

Hospital Molinette of the University Hospital S. Giovanni Battista/City University Hosp of Health an, Turin (Italy)
0 follower

Associate Professor Charbel Abi Khalil

Weill Cornell Medicine - Qatar, Doha (Qatar)
0 follower

Doctor Dan Haberman

Kaplan Medical Center, Rehovot (Israel)
0 follower

Mr Kees Van Der Wulp

University Medical Centre St Radboud (UMCN), Nijmegen (Netherlands (The))
0 follower

Doctor Benoit Lattuca

University Hospital of Nimes, Nimes (France)
0 follower

Doctor Arnaud Bisson

CHU de Tours, Tours (France)
0 follower

Doctor Catarina Brizido

Hospital de Santa Cruz, Carnaxide (Portugal)
0 follower

This platform is supported by

logo Novo Nordisk